Literature DB >> 30500874

A Genome-wide Association Study Identifying RAP1A as a Novel Susceptibility Gene for Crohn's Disease in Japanese Individuals.

Yoichi Kakuta1, Yosuke Kawai2, Takeo Naito1, Atsushi Hirano3, Junji Umeno3, Yuta Fuyuno3, Zhenqiu Liu4, Dalin Li4, Takeru Nakano1, Yasuhiro Izumiyama1, Ryo Ichikawa1, Daisuke Okamoto1, Hiroshi Nagai1, Shin Matsumoto1, Katsutoshi Yamamoto1, Naonobu Yokoyama1, Hirofumi Chiba1, Yusuke Shimoyama1, Motoyuki Onodera1, Rintaro Moroi1, Masatake Kuroha1, Yoshitake Kanazawa1, Tomoya Kimura1, Hisashi Shiga1, Katsuya Endo1, Kenichi Negoro1, Jun Yasuda2, Motohiro Esaki3, Katsushi Tokunaga5, Minoru Nakamura6, Takayuki Matsumoto3,7, Dermot P B McGovern4, Masao Nagasaki2, Yoshitaka Kinouchi8, Tooru Shimosegawa1, Atsushi Masamune1.   

Abstract

BACKGROUND AND AIMS: Genome-wide association studies [GWASs] of European populations have identified numerous susceptibility loci for Crohn's disease [CD]. Susceptibility genes differ by ethnicity, however, so GWASs specific for Asian populations are required. This study aimed to clarify the Japanese-specific genetic background for CD by a GWAS using the Japonica array [JPA] and subsequent imputation with the 1KJPN reference panel.
METHODS: Two independent Japanese case/control sets (Tohoku region [379 CD patients, 1621 controls] and Kyushu region [334 CD patients, 462 controls]) were included. GWASs were performed separately for each population, followed by a meta-analysis. Two additional replication sets [254 + 516 CD patients and 287 + 565 controls] were analysed for top hit single nucleotide polymorphisms [SNPs] from novel genomic regions.
RESULTS: Genotype data of 4 335 144 SNPs from 713 Japanese CD patients and 2083 controls were analysed. SNPs located in TNFSF15 (rs78898421, Pmeta = 2.59 × 10-26, odds ratio [OR] = 2.10), HLA-DQB1 [rs184950714, pmeta = 3.56 × 10-19, OR = 2.05], ZNF365, and 4p14 loci were significantly associated with CD in Japanese individuals. Replication analyses were performed for four novel candidate loci [p <1 × 10-6], and rs488200 located upstream of RAP1A was significantly associated with CD [pcombined = 4.36 × 10-8, OR = 1.31]. Transcriptome analysis of CD4+ effector memory T cells from lamina propria mononuclear cells of CD patients revealed a significant association of rs488200 with RAP1A expression.
CONCLUSIONS: RAP1A is a novel susceptibility locus for CD in the Japanese population.
Copyright © 2018 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. 
For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Crohn’s disease; RAP1A; susceptibility gene

Mesh:

Substances:

Year:  2019        PMID: 30500874      PMCID: PMC7458277          DOI: 10.1093/ecco-jcc/jjy197

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  48 in total

1.  HLA class II alleles in Japanese patients with inflammatory bowel disease.

Authors:  S Yoshitake; A Kimura; M Okada; T Yao; T Sasazuki
Journal:  Tissue Antigens       Date:  1999-04

2.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

3.  Association study of TNFSF15 polymorphisms in Japanese patients with inflammatory bowel disease.

Authors:  Y Kakuta; Y Kinouchi; K Negoro; S Takahashi; T Shimosegawa
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

4.  A genome-wide association study identifies 2 susceptibility Loci for Crohn's disease in a Japanese population.

Authors:  Keiko Yamazaki; Junji Umeno; Atsushi Takahashi; Atsushi Hirano; Todd Andrew Johnson; Natsuhiko Kumasaka; Takashi Morizono; Naoya Hosono; Takaaki Kawaguchi; Masakazu Takazoe; Tetsuhiro Yamada; Yasuo Suzuki; Hiroki Tanaka; Satoshi Motoya; Masayo Hosokawa; Yoshiaki Arimura; Yasuhisa Shinomura; Toshiyuki Matsui; Takayuki Matsumoto; Mitsuo Iida; Tatsuhiko Tsunoda; Yusuke Nakamura; Naoyuki Kamatani; Michiaki Kubo
Journal:  Gastroenterology       Date:  2012-12-22       Impact factor: 22.682

5.  Isoform-specific differences between Rap1A and Rap1B GTPases in the formation of endothelial cell junctions.

Authors:  Erika S Wittchen; Amir Aghajanian; Keith Burridge
Journal:  Small GTPases       Date:  2011-03

6.  Positive association of genetic variants in the upstream region of NKX2-3 with Crohn's disease in Japanese patients.

Authors:  K Yamazaki; A Takahashi; M Takazoe; M Kubo; Y Onouchi; A Fujino; N Kamatani; Y Nakamura; A Hata
Journal:  Gut       Date:  2008-10-20       Impact factor: 23.059

7.  Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.

Authors:  Jimmy Z Liu; Suzanne van Sommeren; Hailiang Huang; Siew C Ng; Rudi Alberts; Atsushi Takahashi; Stephan Ripke; James C Lee; Luke Jostins; Tejas Shah; Shifteh Abedian; Jae Hee Cheon; Judy Cho; Naser E Dayani; Lude Franke; Yuta Fuyuno; Ailsa Hart; Ramesh C Juyal; Garima Juyal; Won Ho Kim; Andrew P Morris; Hossein Poustchi; William G Newman; Vandana Midha; Timothy R Orchard; Homayon Vahedi; Ajit Sood; Joseph Y Sung; Reza Malekzadeh; Harm-Jan Westra; Keiko Yamazaki; Suk-Kyun Yang; Jeffrey C Barrett; Behrooz Z Alizadeh; Miles Parkes; Thelma Bk; Mark J Daly; Michiaki Kubo; Carl A Anderson; Rinse K Weersma
Journal:  Nat Genet       Date:  2015-07-20       Impact factor: 41.307

8.  Rare variant discovery by deep whole-genome sequencing of 1,070 Japanese individuals.

Authors:  Masao Nagasaki; Jun Yasuda; Fumiki Katsuoka; Naoki Nariai; Kaname Kojima; Yosuke Kawai; Yumi Yamaguchi-Kabata; Junji Yokozawa; Inaho Danjoh; Sakae Saito; Yukuto Sato; Takahiro Mimori; Kaoru Tsuda; Rumiko Saito; Xiaoqing Pan; Satoshi Nishikawa; Shin Ito; Yoko Kuroki; Osamu Tanabe; Nobuo Fuse; Shinichi Kuriyama; Hideyasu Kiyomoto; Atsushi Hozawa; Naoko Minegishi; James Douglas Engel; Kengo Kinoshita; Shigeo Kure; Nobuo Yaegashi; Masayuki Yamamoto
Journal:  Nat Commun       Date:  2015-08-21       Impact factor: 14.919

9.  A global reference for human genetic variation.

Authors:  Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

10.  TopHat: discovering splice junctions with RNA-Seq.

Authors:  Cole Trapnell; Lior Pachter; Steven L Salzberg
Journal:  Bioinformatics       Date:  2009-03-16       Impact factor: 6.937

View more
  7 in total

Review 1.  Treatments of inflammatory bowel disease toward personalized medicine.

Authors:  Ki-Uk Kim; Jisu Kim; Wan-Hoon Kim; Hyeyoung Min; Chang Hwan Choi
Journal:  Arch Pharm Res       Date:  2021-03-24       Impact factor: 4.946

2.  An Integrated Genomic and Transcriptomic Analysis Reveals Candidates of Susceptibility Genes for Crohn's Disease in Japanese Populations.

Authors:  Yoichi Kakuta; Ryo Ichikawa; Yuta Fuyuno; Atsushi Hirano; Junji Umeno; Takehiro Torisu; Kazuhiro Watanabe; Akihiro Asakura; Takeru Nakano; Yasuhiro Izumiyama; Daisuke Okamoto; Takeo Naito; Rintaro Moroi; Masatake Kuroha; Yoshitake Kanazawa; Tomoya Kimura; Hisashi Shiga; Takeshi Naito; Motohiro Esaki; Yosuke Kawai; Katsushi Tokunaga; Minoru Nakamura; Takayuki Matsumoto; Masao Nagasaki; Yoshitaka Kinouchi; Michiaki Unno; Atsushi Masamune
Journal:  Sci Rep       Date:  2020-06-24       Impact factor: 4.379

3.  Study Profile of the Tohoku Medical Megabank Community-Based Cohort Study.

Authors:  Atsushi Hozawa; Kozo Tanno; Naoki Nakaya; Tomohiro Nakamura; Naho Tsuchiya; Takumi Hirata; Akira Narita; Mana Kogure; Kotaro Nochioka; Ryohei Sasaki; Nobuyuki Takanashi; Kotaro Otsuka; Kiyomi Sakata; Shinichi Kuriyama; Masahiro Kikuya; Osamu Tanabe; Junichi Sugawara; Kichiya Suzuki; Yoichi Suzuki; Eiichi N Kodama; Nobuo Fuse; Hideyasu Kiyomoto; Hiroaki Tomita; Akira Uruno; Yohei Hamanaka; Hirohito Metoki; Mami Ishikuro; Taku Obara; Tomoko Kobayashi; Kazuyuki Kitatani; Takako Takai-Igarashi; Soichi Ogishima; Mamoru Satoh; Hideki Ohmomo; Akito Tsuboi; Shinichi Egawa; Tadashi Ishii; Kiyoshi Ito; Sadayoshi Ito; Yasuyuki Taki; Naoko Minegishi; Naoto Ishii; Masao Nagasaki; Kazuhiko Igarashi; Seizo Koshiba; Ritsuko Shimizu; Gen Tamiya; Keiko Nakayama; Hozumi Motohashi; Jun Yasuda; Atsushi Shimizu; Tsuyoshi Hachiya; Yuh Shiwa; Teiji Tominaga; Hiroshi Tanaka; Kotaro Oyama; Ryoichi Tanaka; Hiroshi Kawame; Akimune Fukushima; Yasushi Ishigaki; Tomoharu Tokutomi; Noriko Osumi; Tadao Kobayashi; Fuji Nagami; Hiroaki Hashizume; Tomohiko Arai; Yoshio Kawaguchi; Shinichi Higuchi; Masaki Sakaida; Ryujin Endo; Satoshi Nishizuka; Ichiro Tsuji; Jiro Hitomi; Motoyuki Nakamura; Kuniaki Ogasawara; Nobuo Yaegashi; Kengo Kinoshita; Shigeo Kure; Akio Sakai; Seiichiro Kobayashi; Kenji Sobue; Makoto Sasaki; Masayuki Yamamoto
Journal:  J Epidemiol       Date:  2020-01-11       Impact factor: 3.211

4.  TL1A (TNFSF15) genotype affects the long-term therapeutic outcomes of anti-TNFα antibodies for Crohn's disease patients.

Authors:  Katsuya Endo; Yoichi Kakuta; Rintaro Moroi; Katsutoshi Yamamoto; Hisashi Shiga; Masatake Kuroha; Takeo Naito; Yoshitaka Kinouchi; Atsushi Masamune
Journal:  JGH Open       Date:  2020-08-01

5.  A machine learning-based SNP-set analysis approach for identifying disease-associated susceptibility loci.

Authors:  Princess P Silva; Joverlyn D Gaudillo; Julianne A Vilela; Ranzivelle Marianne L Roxas-Villanueva; Beatrice J Tiangco; Mario R Domingo; Jason R Albia
Journal:  Sci Rep       Date:  2022-09-22       Impact factor: 4.996

Review 6.  Genetic Studies of Inflammatory Bowel Disease-Focusing on Asian Patients.

Authors:  Sung Chul Park; Yoon Tae Jeen
Journal:  Cells       Date:  2019-05-01       Impact factor: 6.600

7.  Host Genetic and Gut Microbial Signatures in Familial Inflammatory Bowel Disease.

Authors:  Yoo Min Park; Eunji Ha; Ki-Nam Gu; Ga Young Shin; Chang Kyun Lee; Kwangwoo Kim; Hyo Jong Kim
Journal:  Clin Transl Gastroenterol       Date:  2020-07       Impact factor: 4.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.